John Boukovinas

Learn More
BACKGROUND Paclitaxel (Taxol) and vinorelbine have shown synergism of cytotoxic effects in vitro and clinical activity in phase I and II studies. This combination was compared prospectively with the(More)
Our purpose was to determine the response rate and median and overall survival of gemcitabine as monotherapy versus gemcitabine plus irinotecan in advanced or metastatic pancreatic cancer. Patients(More)
BACKGROUND This trial was designed to compare the efficacy and toxicity of sequential versus alternating administration of cisplatin/etoposide and topotecan in patients with previously untreated(More)
5108 Background: To evaluate the efficacy and toxicity of the sequential administration of paclitaxel-carboplatin (T/C) and paclitaxel-liposomal doxorubicin (T/D) as 1st line treatment in pts with(More)
728 Background: To evaluate the activity and toxicity of the docetaxel-gemcitabine-trastuzumab combination in the first-line treatment of ABC overexpressing HER-2. METHODS Previously untreated(More)
UNLABELLED Concurrent chemoradiotherapy has become a standard therapy for locoregionally advanced inoperable nonsmall cell lung cancer (NSCLC). The purpose of this phase II trial was to evaluate the(More)
  • 1